Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:BBP NYSEARCA:GDOC NYSEARCA:MEDI NASDAQ:MEDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBPVirtus LifeSci Biotech Products ETF$62.04+1.7%$58.01$48.65▼$69.12$24.82M0.732,407 shs5,695 shsGDOCGoldman Sachs Future Health Care Equity ETF$31.23+0.5%$31.35$28.34▼$37.23$19.52M0.841,686 shs569 shsMEDIHarbor Health Care ETF$26.93+0.3%$25.72$21.86▼$28.40$16.83M12,082 shs459 shsMEDXHorizon Kinetics Medical ETF$27.76+1.5%$26.52$23.46▼$32.00$15.82M0.911,451 shs851 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBPVirtus LifeSci Biotech Products ETF-2.20%+2.01%+1.67%+13.98%-3.77%GDOCGoldman Sachs Future Health Care Equity ETF-1.89%-0.73%-2.23%+2.51%-13.33%MEDIHarbor Health Care ETF-1.54%+1.59%+1.82%+9.11%+0.36%MEDXHorizon Kinetics Medical ETF-1.94%-0.48%+0.74%+10.65%-11.16%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBPVirtus LifeSci Biotech Products ETFN/AN/AN/AN/AN/AN/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDIHarbor Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBPVirtus LifeSci Biotech Products ETF 2.79Moderate Buy$62.100.10% UpsideGDOCGoldman Sachs Future Health Care Equity ETF 2.79Moderate Buy$31.23N/AMEDIHarbor Health Care ETF 2.87Moderate Buy$26.93N/AMEDXHorizon Kinetics Medical ETF 2.65Moderate Buy$27.76N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBPVirtus LifeSci Biotech Products ETFN/AN/AN/AN/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AN/AN/AN/AN/AN/AMEDIHarbor Health Care ETFN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBPVirtus LifeSci Biotech Products ETFN/AN/A0.00∞N/AN/AN/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AN/A28.36∞N/AN/AN/AN/AN/AMEDIHarbor Health Care ETFN/AN/A35.66∞N/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/A19.02∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBPVirtus LifeSci Biotech Products ETF$0.070.12%N/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/A0.02%N/AN/AN/AMEDIHarbor Health Care ETF$0.130.48%N/AN/AN/AMEDXHorizon Kinetics Medical ETF$0.501.80%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBPVirtus LifeSci Biotech Products ETFN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AMEDIHarbor Health Care ETFN/AMEDXHorizon Kinetics Medical ETF62.18%Insider OwnershipCompanyInsider OwnershipBBPVirtus LifeSci Biotech Products ETFN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AMEDIHarbor Health Care ETFN/AMEDXHorizon Kinetics Medical ETF4.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBPVirtus LifeSci Biotech Products ETFN/A400,000N/ANot OptionableGDOCGoldman Sachs Future Health Care Equity ETFN/A625,000N/ANot OptionableMEDIHarbor Health Care ETFN/A625,000N/ANot OptionableMEDXHorizon Kinetics Medical ETFN/A570,000N/ANot OptionableGDOC, MEDI, MEDX, and BBP HeadlinesRecent News About These CompaniesHorizon Kinetics Holding Corporation Reports First Quarter ResultsMay 14, 2025 | accessnewswire.comAHorizon Kinetics Holding Corporation Reports Fourth Quarter and Annual ResultsMarch 26, 2025 | accessnewswire.comAETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts OutlookMay 1, 2024 | zacks.comHorizon Kinetics ISE Wealth (RCH)May 13, 2023 | uk.investing.comHORIZON Fushi ChinaA 50 ETF (512150)May 11, 2023 | investing.comHorizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)April 19, 2023 | finance.yahoo.comMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendSalesforce Raises Prices: 3 Reasons Its Stock Price Will FollowBy Thomas Hughes | June 18, 2025View Salesforce Raises Prices: 3 Reasons Its Stock Price Will FollowBuybacks Galore: Repurchases From the Oval Office to Olive GardenBy Leo Miller | June 30, 2025View Buybacks Galore: Repurchases From the Oval Office to Olive GardenAre Growth Stocks Back? 3 That Look Like Winners to Buy NowBy Jeffrey Neal Johnson | July 10, 2025View Are Growth Stocks Back? 3 That Look Like Winners to Buy NowGDOC, MEDI, MEDX, and BBP Company DescriptionsVirtus LifeSci Biotech Products ETF NYSEARCA:BBP$62.04 +1.04 (+1.70%) As of 01:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.Goldman Sachs Future Health Care Equity ETF NYSEARCA:GDOC$31.23 +0.16 (+0.51%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Goldman Sachs Future Health Care Equity ETF (GDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. GDOC was launched on Nov 9, 2021 and is managed by Goldman Sachs.Harbor Health Care ETF NYSEARCA:MEDI$26.93 +0.09 (+0.34%) As of 12:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Harbor Health Care ETF (MEDI) is an exchange-traded fund that is based on the Russell 3000 Growth Health Care index. The fund seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally. MEDI was launched on Nov 16, 2022 and is managed by Harbor.Horizon Kinetics Medical ETF NASDAQ:MEDX$27.76 +0.42 (+1.52%) As of 02:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
